Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 178

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

NF-κB as a Key Mediator of Brain Inflammation in Alzheimer’s Disease

Ju Hwang, Chul, Choi, Dong-Young, Park, Mi Hee, Hong, Jin Tae · 2019 · CNS & Neurological Disorders - Drug Targets

Abstract

Alzheimer’s disease is the most common form of dementia. It is characterized by betaamyloid peptide fibrils which are extracellular deposition of a specific protein, accompanied by extensive neuroinflammation. Various studies show the presence of a number of inflammation markers in the AD brain: elevated inflammatory cytokines and chemokines, and an accumulation of activated microglia in the damaged regions. NF-κB is a family of redox sensitive transcriptional factors, and it is known that NF-κB has binding sites in the promoter region of the genes involved in amyloidogenesis and inflammation. Long-term use of non-steroidal anti-inflammatory drugs prevents progression of AD and delays its onset, suggesting that there is a close correlation between NF-κB and AD pathogenesis. This study aims to (1) assess the association between NF-κB activity and AD through discussion of a variety of experimental and clinical studies on AD and (2) review treatment strategies designed to treat or prevent AD with NF-κB inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1871527316666170807130011

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 86

  1. Frantz S, Tillmanns J, Kuhlencordt PJ. Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. · DOI
  2. Blennow K, de Leon MJ, Zetterberg H. Alzheimer’s disease. · DOI · Paper page
  3. Eckman EA, Eckman CB. Abeta-degrading enzymes: Modulators of Alzheimer’s disease pathogenesis and targets for therapeutic intervention. · doi:10.1042/bst0331101 · Paper page
  4. Nalivaeva NN, Fisk LR, Belyaev ND, Turner AJ. Amyloid-degrading enzymes as therapeutic targets in Alzheimer’s disease. · DOI · Paper page
  5. Crews F, Nixon K, Kim D. BHT blocks NF-kappaB activation and ethanol-induced brain damage. · DOI · Paper page
  6. Bourne KZ, Ferrari DC, Lange-Dohna C, Rossner S, Wood TG, Perez-Polo JR. Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. · DOI · Paper page
  7. Grilli M, Goffi F, Memo M, Spano P. Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. · DOI
  8. Yang L, Tao LY, Chen XP. Roles of NF-kappaB in central nervous system damage and repair.
  9. Hwang CJ, Yun HM, Jung YY. Reducing effect of IL-32alpha in the development of stroke through blocking of NF-kappaB, but enhancement of STAT3 pathways. · DOI
  10. Nijboer CH, Heijnen CJ, Groenendaal F, May MJ, van Bel F, Kavelaars A. Strong neuroprotection by inhibition of NF-kappaB after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. · DOI
  11. Goodman Y, Mattson MP. Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. · DOI · Paper page
  12. Mattson MP, Goodman Y, Luo H, Fu W, Furukawa K. Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: Evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration. · DOI · Paper page
  13. Meffert MK, Chang JM, Wiltgen BJ, Fanselow MS, Baltimore D. NF-kappa B functions in synaptic signaling and behavior. · DOI · Paper page
  14. Imielski Y, Schwamborn JC, Luningschror P. Regrowing the adult brain: NF-kappaB controls functional circuit formation and tissue homeostasis in the dentate gyrus. · DOI
  15. Barger SW, Horster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: Evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca accumulation. · DOI · Paper page
  16. Bhakar AL, Tannis LL, Zeindler C. Constitutive nuclear factor-kappa B activity is required for central neuron survival. · DOI · Paper page
  17. Blondeau N, Widmann C, Lazdunski M, Heurteaux C. Activation of the nuclear factor-kappaB is a key event in brain tolerance. The Journal of neuroscience. · DOI · Paper page
  18. Kassed CA, Butler TL, Patton GW. Injury-induced NF-kappaB activation in the hippocampus: Implications for neuronal survival. · DOI
  19. Yu Z, Zhou D, Bruce-Keller AJ, Kindy MS, Mattson MP. Lack of the p50 subunit of nuclear factor-kappaB increases the vulnerability of hippocampal neurons to excitotoxic injury. · DOI · Paper page
  20. Yu Z, Zhou D, Cheng G, Mattson MP. Neuroprotective role for the p50 subunit of NF-kappaB in an experimental model of Huntington’s disease. · DOI
  21. Sambamurti K, Kinsey R, Maloney B, Ge YW, Lahiri DK. Gene structure and organization of the human beta-secretase (BACE) promoter. · DOI · Paper page
  22. Han Z, Boyle DL, Manning AM, Firestein GS. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collagen-induced arthritis. · DOI · Paper page
  23. Wang L, Zhang X, Liu L. Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-kappaB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia. · DOI
  24. Cui L, Zhang X, Yang R. Baicalein is neuroprotective in rat MCAO model: Role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2. · DOI
  25. Liu Y, Zhang XJ, Yang CH, Fan HG. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression. · DOI
  26. Hunot S, Brugg B, Ricard D. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. · DOI · Paper page
  27. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. · DOI · Paper page
  28. Wu D, Cerutti C, Lopez-Ramirez MA. Brain endothelial miR-146a negatively modulates T-cell adhesion through repressing multiple targets to inhibit NF-kappaB activation. · DOI
  29. Peng X, Nie Y, Wu J, Huang Q, Cheng Y. Juglone prevents metabolic endotoxemia-induced hepatitis and neuroinflammation suppressing TLR4/NF-kappaB signaling pathway in high-fat diet rats. · DOI
  30. Li Y, Zhao L, Fu H, Wu Y, Wang T. Ulinastatin suppresses lipopolysaccharide induced neuro-inflammation through the downregulation of nuclear factor-kappaB in SD rat hippocampal astrocyte. · DOI
  31. Sung YH, Shin MS, Ko IG. Ulinastatin suppresses lipopolysaccharide-induced prostaglandin E2 synthesis and nitric oxide production through the downregulation of nuclear factorkappaB in BV2 mouse microglial cells. · DOI
  32. Ridet JL, Malhotra SK, Privat A, Gage FH. Reactive astrocytes: Cellular and molecular cues to biological function. · DOI · Paper page
  33. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. · DOI · Paper page
  34. Liberto CM, Albrecht PJ, Herx LM, Yong VW, Levison SW. Pro-regenerative properties of cytokine-activated astrocytes. · DOI · Paper page
  35. de Freitas MS, Spohr TC, Benedito AB. Neurite outgrowth is impaired on HSP70-positive astrocytes through a mechanism that requires NF-kappaB activation. · DOI
  36. Schwaninger M, Sallmann S, Petersen N. Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB. · DOI
  37. Acarin L, Gonzalez B, Castellano B. Triflusal posttreatment inhibits glial nuclear factor-kappaB, downregulates the glial response, and is neuroprotective in an excitotoxic injury model in postnatal brain. · DOI
  38. Brambilla R, Bracchi-Ricard V, Hu WH. Inhibition of astroglial nuclear factor kappa B reduces inflammation and improves functional recovery after spinal cord injury. · DOI · Paper page
  39. Jana M, Liu X, Koka S, Ghosh S, Petro TM, Pahan K. Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. · DOI
  40. Rasley A, Anguita J, Marriott I. Borrelia burgdorferi induces inflammatory mediator production by murine microglia. · DOI
  41. Moriyama N, Taniguchi M, Miyano K, Miyoshi M, Watanabe T. ANP inhibits LPS-induced stimulation of rat microglial cells by suppressing NF-kappaB and AP-1 activations. · DOI
  42. Matsuoka Y, Kitamura Y, Okazaki M, Terai K, Taniguchi T. Kainic acid-induced activation of nuclear factor-kappaB in rat hippocampus. · DOI
  43. Acarin L, Gonzalez B, Castellano B. STAT3 and NFkappaB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. · DOI
  44. Khasnavis S, Jana A, Roy A. Suppression of nuclear factor-kappaB activation and inflammation in microglia by physically modified saline. · DOI
  45. Heese K, Fiebich BL, Bauer J, Otten U. NF-kappaB modulates lipopolysaccharide-induced microglial nerve growth factor expression. · DOI
  46. Steinman L. Nuanced roles of cytokines in three major human brain disorders. · DOI
  47. Rahman SM, Van Dam AM, Schultzberg M, Crisby M. High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice. · DOI
  48. Sheng JG, Ito K, Skinner RD. and evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis. · DOI · Paper page
  49. Lehmann ML, Brachman RA, Listwak SJ, Herkenham M. NF-kappaB activity affects learning in aversive tasks: Possible actions modulation of the stress axis. · DOI
  50. Hla T, Ristimaki A, Appleby S, Barriocanal JG. Cyclooxygenase gene expression in inflammation and angiogenesis. · DOI · Paper page
  51. Lee YJ, Choi IS, Park MH. 4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway. · DOI
  52. Li R, Yang L, Lindholm K. Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death. · DOI · Paper page
  53. Lee YJ, Choi DY, Choi IS. Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-beta generation and inflammatory reactions inhibition of NF-kappaB and STAT3 activation in cultured astrocytes and microglial BV-2 cells. · DOI
  54. Ban JO, Oh JH, Kim TM. Anti-inflammatory and arthritic effects of thiacremonone, a novel sulfur compound isolated from garlic inhibition of NF-kappaB. · DOI
  55. Choi IS, Lee YJ, Choi DY. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-beta generation and accumulation in a mouse model of Alzheimer’s disease. · DOI
  56. Kim JA, Yun HM, Jin P. Inhibitory effect of a 2,4-bis(4-hydroxyphenyl)-2-butenal diacetate on neuro-inflammatory reactions inhibition of STAT1 and STAT3 activation in cultured astrocytes and microglial BV-2 cells.
  57. Lee JW, Lee YK, Ban JO. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity inhibition of ERK and NF-kappaB pathways in mice. · DOI · Paper page
  58. Lee YJ, Choi DY, Choi IS. Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment inhibition of nuclear factor-kappaB and models. · DOI
  59. Lee YK, Yuk DY, Lee JW. (-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency. · DOI · Paper page
  60. Lin GH, Lee YJ, Choi DY. Anti-amyloidogenic effect of thiacremonone through anti-inflamation and models. · DOI
  61. Terai K, Matsuo A, McGeer PL. Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer’s disease. · DOI · Paper page
  62. Boissiere F, Hunot S, Faucheux B. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer’s disease. · DOI
  63. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. · DOI · Paper page
  64. Lukiw WJ, Bazan NG. Strong nuclear factor-kappaB-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic Alzheimer’s disease superior temporal lobe neocortex. · DOI
  65. Hensley K. Neuroinflammation in Alzheimer’s disease: Mechanisms, pathologic consequences, and potential for therapeutic manipulation. · DOI · Paper page
  66. Choi DY, Lee JW, Lin G. Obovatol attenuates LPS-induced memory impairments in mice inhibition of NF-kappaB signaling pathway. · DOI
  67. Shi JQ, Zhang CC, Sun XL. Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation. · DOI
  68. Zhang X, Luhrs KJ, Ryff KA, Malik WT, Driscoll MJ, Culver B. Suppression of nuclear factor kappa B ameliorates astrogliosis but not amyloid burden in APPswe/PS1dE9 mice. · DOI
  69. Echeverria V, Burgess S, Gamble-George J. Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. · DOI
  70. Wu J, Wang A, Min Z. Lipoxin A4 inhibits the production of proinflammatory cytokines induced by beta-amyloid and · DOI
  71. Gong QH, Pan LL, Liu XH, Wang Q, Huang H, Zhu YZ. S-propargyl-cysteine (ZYZ-802), a sulphur-containing amino acid, attenuates beta-amyloid-induced cognitive deficits and pro-inflammatory response: Involvement of ERK1/2 and NF-kappaB pathway in rats. · DOI
  72. Gong QH, Wang Q, Pan LL, Liu XH, Xin H, Zhu YZ. S-propargyl-cysteine, a novel hydrogen sulfide-modulated agent, attenuates lipopolysaccharide-induced spatial learning and memory impairment: Involvement of TNF signaling and NF-kappaB pathway in rats. · DOI
  73. Yu X, Wang LN, Du QM. Akebia Saponin D attenuates amyloid beta-induced cognitive deficits and inflammatory response in rats: Involvement of Akt/NF-kappaB pathway. · DOI
  74. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. · DOI · Paper page
  75. Natarajan K, Singh S, Burke TR, Grunberger D, Aggarwal BB. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B. · DOI · Paper page
  76. Takada Y, Aggarwal BB. Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: Abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. · DOI · Paper page
  77. Park YM, Won JH, Yun KJ. Preventive effect of Ginkgo biloba extract (GBB) on the lipopolysaccharide-induced expressions of inducible nitric oxide synthase and cyclooxygenase-2 suppression of nuclear factor-kappaB in RAW 264.7 cells. · DOI
  78. Bae UJ. Lee da Y, Song MY, A prenylated flavan from Broussonetia kazinoki prevents cytokine-induced beta-cell death through suppression of nuclear factor-kappaB activity. · DOI
  79. Wang HM, Zhang T, Huang JK, Sun XJ. 3-N-butylphthalide (NBP) attenuates the amyloid-beta-induced inflammatory responses in cultured astrocytes the nuclear factor-kappaB signaling pathway. · DOI
  80. Lee YY, Park JS, Jung JS, Kim DH, Kim HS. Anti-Inflammatory effect of ginsenoside Rg5 in lipopolysaccharide-stimulated BV2 microglial cells. · DOI
  81. Kang CH, Jayasooriya RG, Dilshara MG. Caffeine suppresses lipopolysaccharide-stimulated BV2 microglial cells by suppressing Akt-mediated NF-kappaB activation and ERK phosphorylation. · DOI
  82. Cheong MH, Lee SR, Yoo HS. Anti-inflammatory effects of Polygala tenuifolia root through inhibition of NF-kappa B activation in lipopolysaccharide-induced BV2 microglial cells. · DOI
  83. . Lee da Y, Li H, Lim HJ, Lee HJ, Jeon R, Ryu JH. Anti-inflammatory activity of sulfur-containing compounds from garlic. · DOI
  84. Kwon HK, Hwang JS, So JS. Cinnamon extract induces tumor cell death through inhibition of NF kappa B and AP1. · DOI · Paper page
  85. Ghiso J, Frangione B. Amyloidosis and Alzheimer’s disease. · DOI · Paper page
  86. Selkoe DJ. Clearing the brain’s amyloid cobwebs. · DOI · Paper page

Cited by

See all 178

Metadata

Authors
Ju Hwang, C., Choi, D.-Y., Park, M. H., & Hong, J. T.
Venue
CNS & Neurological Disorders - Drug Targets
Published
2019-02-21
Volume
18
Issue
1
Pages
3-10
ISSN
  • 1568-007X (ISSN-L)
  • 1871-5273
OpenAlex
W2743513023
Cited by
178
References
10
FWCI
4.64
Type
journal article
Language
en
Open access
closed
Funders
National Research Foundation of Korea (MRC-2008-0062275)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NF-κB as a Key Mediator of Brain Inflammation in Alzheimer’s Disease. https://app.cochat.ai/papers/10.2174/1871527316666170807130011
The paper
Ju Hwang, C., Choi, D.-Y., Park, M. H., & Hong, J. T. (2019). NF-κB as a Key Mediator of Brain Inflammation in Alzheimer’s Disease. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527316666170807130011

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.